Regarding cancer, in 1998, it was first found that HLA-G expression is restricted to melanoma lesions, but not in adjacent normal skin tissues, and that HLA-G could inhibit NK cell function to enhance cancer immune evasion (11). This evidence concerns the gene HLA-G and cancer.